Epidemiological characteristics of common respiratory infectious diseases in children before and during the COVID-19 epidemic.
COVID-19
children
influenza
measles
mumps
pertussis
pulmonary tuberculosis
scarlet fever
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2023
2023
Historique:
received:
26
04
2023
accepted:
25
07
2023
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Since the outbreak of coronavirus disease 2019 (COVID-19), public's awareness of infection prevention and control has increased overall, and various prevention and control measures have been adopted. These measures may also have a certain impact on the occurrence of other infectious diseases. Therefore, we collected information on children with several respiratory infectious diseases in Jinan Children's Hospital in China from 2016 to 2022 and analyzed their changes. We collected data on age, sex and number of cases of pertussis, measles, scarlet fever, pulmonary tuberculosis, mumps and influenza, which were diagnosed by clinical and laboratory criteria, from 1 January 2016 to 31 December 2022 in Jinan Children's Hospital in Jinan, Shandong Province, China. Data on the number of people affected by these diseases in China from the Chinese Center for Disease Control and Prevention were compared. Then, we processed the data by using WPS Excel 2019 and SPSS. A total of 12,225 cases were included in this study in Jinan Children's Hospital, which consisted of 3,688 cases of pertussis (2,200 cases before COVID-19 and 1,488 during COVID-19), 680 cases of measles (650 cases before COVID-19 and 30 during COVID-19), 4,688 cases of scarlet fever (4,001 cases before COVID-19 and 687 during COVID-19), 114 cases of tuberculosis (86 cases before COVID-19 and 28 during COVID-19), 449 cases of mumps (340 cases before COVID-19 and 109 during COVID-19) and 2,606 cases of influenza (1,051 cases before COVID-19 and 1,555 during COVID-19). The numbers of children in the hospital with pertussis, measles, scarlet fever, mumps and influenza decreased substantially during COVID-19 in 2020-2022 compared with numbers in 2016-2019, while numbers of patients in China with all six respiratory infectious diseases, including pulmonary tuberculosis, declined during the pandemic. A rebound of pertussis, scarlet fever and influenza was observed in 2021 and 2022. The study found that viral pathogens such as those causing measles, mumps and influenza all decreased during the pandemic, after which influenza rebounded. Infection diseases caused by bacteria such as scarlet fever and pertussis also decreased during COVID-19, and then a rebound occurred. However, tuberculosis stayed relatively constant.
Sections du résumé
Background
UNASSIGNED
Since the outbreak of coronavirus disease 2019 (COVID-19), public's awareness of infection prevention and control has increased overall, and various prevention and control measures have been adopted. These measures may also have a certain impact on the occurrence of other infectious diseases. Therefore, we collected information on children with several respiratory infectious diseases in Jinan Children's Hospital in China from 2016 to 2022 and analyzed their changes.
Method
UNASSIGNED
We collected data on age, sex and number of cases of pertussis, measles, scarlet fever, pulmonary tuberculosis, mumps and influenza, which were diagnosed by clinical and laboratory criteria, from 1 January 2016 to 31 December 2022 in Jinan Children's Hospital in Jinan, Shandong Province, China. Data on the number of people affected by these diseases in China from the Chinese Center for Disease Control and Prevention were compared. Then, we processed the data by using WPS Excel 2019 and SPSS.
Results
UNASSIGNED
A total of 12,225 cases were included in this study in Jinan Children's Hospital, which consisted of 3,688 cases of pertussis (2,200 cases before COVID-19 and 1,488 during COVID-19), 680 cases of measles (650 cases before COVID-19 and 30 during COVID-19), 4,688 cases of scarlet fever (4,001 cases before COVID-19 and 687 during COVID-19), 114 cases of tuberculosis (86 cases before COVID-19 and 28 during COVID-19), 449 cases of mumps (340 cases before COVID-19 and 109 during COVID-19) and 2,606 cases of influenza (1,051 cases before COVID-19 and 1,555 during COVID-19). The numbers of children in the hospital with pertussis, measles, scarlet fever, mumps and influenza decreased substantially during COVID-19 in 2020-2022 compared with numbers in 2016-2019, while numbers of patients in China with all six respiratory infectious diseases, including pulmonary tuberculosis, declined during the pandemic. A rebound of pertussis, scarlet fever and influenza was observed in 2021 and 2022.
Conclusions
UNASSIGNED
The study found that viral pathogens such as those causing measles, mumps and influenza all decreased during the pandemic, after which influenza rebounded. Infection diseases caused by bacteria such as scarlet fever and pertussis also decreased during COVID-19, and then a rebound occurred. However, tuberculosis stayed relatively constant.
Identifiants
pubmed: 37601133
doi: 10.3389/fped.2023.1212658
pmc: PMC10435660
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1212658Informations de copyright
© 2023 Wang, Gai, Han, Liu, Zhang, Sun, Liu, Yu, Peng, Wei, Chang, Ma and Gai.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pediatr Infect Dis J. 2017 Jan;36(1):119-121
pubmed: 27956730
Arch Med Res. 2022 Jan;53(1):1-8
pubmed: 34311990
Int J Infect Dis. 2022 Sep;122:1002-1004
pubmed: 35932966
Travel Med Infect Dis. 2022 Jul-Aug;48:102348
pubmed: 35523394
Int J Environ Res Public Health. 2021 Jun 03;18(11):
pubmed: 34205018
Euro Surveill. 2014 Mar 27;19(12):20749
pubmed: 24698137
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Jan;20(1):1-4
pubmed: 29335073
Nat Commun. 2021 Nov 26;12(1):6923
pubmed: 34836947
Front Public Health. 2021 Nov 10;9:771638
pubmed: 34858936
N Engl J Med. 2012 Aug 30;367(9):785-7
pubmed: 22894554
Nurs Stand. 2016 Apr 27;30(35):17
pubmed: 27191292
Pediatr Infect Dis J. 2013 Feb;32(2):195-6
pubmed: 23328828
J Med Virol. 2021 Jan;93(1):153-154
pubmed: 32617991
JAMA Pediatr. 2020 Oct 1;174(10):e202430
pubmed: 32492092
Zhonghua Er Ke Za Zhi. 2017 Aug 2;55(8):568-572
pubmed: 28822429
PLoS One. 2017 Jan 13;12(1):e0169561
pubmed: 28085897
Emerg Microbes Infect. 2020 Dec;9(1):707-713
pubmed: 32208917
Lancet. 2008 Mar 15;371(9616):932-44
pubmed: 18342688
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Wkly Epidemiol Rec. 2007 Feb 16;82(7):51-60
pubmed: 17304707
Am Fam Physician. 2019 Dec 15;100(12):751-758
pubmed: 31845781
J Infect. 2022 Feb;84(2):e13-e15
pubmed: 34953908
Lancet Reg Health Eur. 2022 Nov;22:100497
pubmed: 36034052
Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Feb 6;57(2):281-285
pubmed: 36797589
Emerg Infect Dis. 2020 Oct;26(10):2509-2511
pubmed: 32730735
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1563-1569
pubmed: 34758014